194 reports of this reaction
1.4% of all TETRABENAZINE reports
#18 most reported adverse reaction
PRESCRIBED OVERDOSE is the #18 most commonly reported adverse reaction for TETRABENAZINE, manufactured by Lundbeck Pharmaceuticals LLC. There are 194 FDA adverse event reports linking TETRABENAZINE to PRESCRIBED OVERDOSE. This represents approximately 1.4% of all 13,933 adverse event reports for this drug.
Patients taking TETRABENAZINE who experience prescribed overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRESCRIBED OVERDOSE is a less commonly reported adverse event for TETRABENAZINE, but still significant enough to appear in the safety profile.
In addition to prescribed overdose, the following adverse reactions have been reported for TETRABENAZINE:
The following drugs have also been linked to prescribed overdose in FDA adverse event reports:
PRESCRIBED OVERDOSE has been reported as an adverse event in 194 FDA reports for TETRABENAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRESCRIBED OVERDOSE accounts for approximately 1.4% of all adverse event reports for TETRABENAZINE, making it a notable side effect.
If you experience prescribed overdose while taking TETRABENAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.